FDA clears first AI test predicting breast cancer risk from a pathology slide; another risk tool available nationwide
The first AI test that predicts breast cancer risk from a pathology slide has received FDA clearance. Another AI tool that estimates breast cancer risk is available nationwide, and the startup is taking it directly to patients.
Who is affected and how
- doctor
- Pathologists and oncologists may gain access to new risk information based on tissue samples.
- medtech company
- Reaching patients directly raises new sales and regulatory questions.
Sources
- The First AI Test That Predicts Breast Cancer Risk From a Pathology Slide Just Cleared the FDA — Ai Data Newsaidatanews.com · Oct 8, 2026
- AI in Pathology: FDA Clearances, Foundation Models & Newssuperiorbiodx.com · Oct 9, 2026
- An AI Tool That Predicts Breast Cancer Risk Is Now Available Nationwideeveryday health · Oct 6, 2026
- This AI Breast Cancer Risk Test Is Finally Available Nationwide—and You Can Order It From Homeoprah daily · Oct 8, 2026
- Why this startup is taking its AI to predict breast cancer risk directly to patientsstat · Oct 8, 2026
- Why this startup is taking its AI to predict breast-cancer risk directly to patients | STATstatnews.com · Oct 8, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.